The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
Faculty Articles
Part of the Medicine and Health Sciences Commons
Part of the Medicine and Health Sciences Commons